Informational Message: Tomorrow, Tuesday, September 28 – CDC COCA Call: “What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination
The Centers for Disease Control and Prevention (CDC) is hosting a Clinician Outreach and Communication Activity (COCA) Call tomorrow, Tuesday, September 28, 2021 from 2:00 to 3:00 PM EST regarding CDC recommendations for the Pfizer-BioNTech booster dose. Registration is not required. Information regarding this COCA Call is included below.
What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination
Overview
This COCA Call will give clinicians an overview of the Pfizer-BioNTech COVID-19 booster vaccination. Clinicians will learn about the vaccine booster recommendations, safety of booster dose, and clinical guidance for using the Pfizer-BioNTech COVID-19 booster vaccine.
If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.
The slide set will be available on the day of the call on the COCA Call webpage under “Call Materials”.
CE will not be offered for this COCA Call.
Registration is not required.
Date: Tuesday, September 28, 2021
Time: 2:00 PM 3:00 PM ET
A few minutes before the webinar starts, please click on the Zoom link below to join:
https://www.zoomgov.com/j/1602551375?pwd=MlllclovakpROFZBU1pYNmlIZE1Ydz09
Passcode: 163147
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
Or One-tap mobile:
US: +16692545252,,1602551375#,,,,*163147# or +16468287666,,1602551375#,,,,*163147#
Webinar ID: 160 255 1375
International numbers available: https://www.zoomgov.com/u/azlZAVzR
COCA Call Objectives:
At the conclusion of the session, the participant will be able to accomplish the following
Cite background information on the topic covered during the presentation.
Discuss CDC’s role in the topic covered during the presentation.
Describe the topic’s implications for clinicians.
Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA products.
For information about this update or other clinical issues, or to send your feedback, please contact: coca@cdc.gov.
NYSHFA/NYSCAL CONTACTS:
Jackie Pappalardi, RN, BSN
Executive Director
518-462-4800 x16
Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
518-462-4800 x15
